Clinical trial
Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer
NCT00009971 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00009971 |
|---|---|
| Title | Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer |
| Official title | Phase II Trial Of Fenretinide (NSC-374551; IND-40, 294) In Patients With Relapsed Small Cell Lung Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | fenretinide |
| Enrollment | 32 |
| Start date | Nov 1, 2000 |
| Primary completion | Sep 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: